Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Feehan, Amy K., Fort, Daniel, Garcia-Diaz, Julia, Price-Haywood, Eboni G., Velasco, Cruz, Sapp, Eric, Pevey, Dawn, Seoane, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588526/
https://www.ncbi.nlm.nih.gov/pubmed/32731911
http://dx.doi.org/10.3201/eid2611.203029
_version_ 1783600389339217920
author Feehan, Amy K.
Fort, Daniel
Garcia-Diaz, Julia
Price-Haywood, Eboni G.
Velasco, Cruz
Sapp, Eric
Pevey, Dawn
Seoane, Leonardo
author_facet Feehan, Amy K.
Fort, Daniel
Garcia-Diaz, Julia
Price-Haywood, Eboni G.
Velasco, Cruz
Sapp, Eric
Pevey, Dawn
Seoane, Leonardo
author_sort Feehan, Amy K.
collection PubMed
description Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
format Online
Article
Text
id pubmed-7588526
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-75885262020-11-01 Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020 Feehan, Amy K. Fort, Daniel Garcia-Diaz, Julia Price-Haywood, Eboni G. Velasco, Cruz Sapp, Eric Pevey, Dawn Seoane, Leonardo Emerg Infect Dis Research Letter Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%. Centers for Disease Control and Prevention 2020-11 /pmc/articles/PMC7588526/ /pubmed/32731911 http://dx.doi.org/10.3201/eid2611.203029 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Feehan, Amy K.
Fort, Daniel
Garcia-Diaz, Julia
Price-Haywood, Eboni G.
Velasco, Cruz
Sapp, Eric
Pevey, Dawn
Seoane, Leonardo
Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_full Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_fullStr Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_full_unstemmed Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_short Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_sort seroprevalence of sars-cov-2 and infection fatality ratio, orleans and jefferson parishes, louisiana, usa, may 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588526/
https://www.ncbi.nlm.nih.gov/pubmed/32731911
http://dx.doi.org/10.3201/eid2611.203029
work_keys_str_mv AT feehanamyk seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT fortdaniel seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT garciadiazjulia seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT pricehaywoodebonig seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT velascocruz seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT sapperic seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT peveydawn seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT seoaneleonardo seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020

Ejemplares similares